Philips Extends Leadership In Patient Monitoring By Buying BioTelemetry For $2.8Bn

Philips is already the leader in hospital patient monitoring and adding BioTelemetry will make it also the top provider of ambulatory cardiac diagnostics and monitoring systems.

Philips
• Source: shutterstock.com

Philips has agreed to pay $2.8bn for BioTelemetry, Inc., dramatically expanding its market-leading patient care monitoring business.

Philips claims the top position in the hospital patient monitoring services, respiratory care and sleep care markets. BioTelemetry is the largest provider of cardiac diagnostics and monitoring outside of hospitals.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business